Congress is pushing to close loopholes
In a recent study published in the Journal of Medical Economics , a group of researchers evaluated the cost-effectiveness of tirzepatide compared with semaglutide for adults with obesity or overweight in the United States (U.S.) using a lifetime simulation model informed by the SURMOUNT-5 head-to-head trial population without type 2 diabetes (T2D)
Compounded Semaglutide is a customized version of the FDA-approved Semaglutide - the active ingredient in leading weight loss medications
Whats more, the GLP-1 Companion has high daily-to-monthly usage ratios, reflecting a level of engagement more on par with a social application than a behavior change program
Always consult your product's Patient Information Leaflet for specific guidance
Whether you pay that depends on your coverage, prior authorization, and savings programs, but some people microdose simply because thats the most affordable option for treatment
